Novel Strategies in Ischemic Heart Disease

00 preface_ Novel Strategies in Ischemic Heart Disease......Page 1
Part 1......Page 13
01_Overview of Coronary Artery Disease......Page 15
Part 2......Page 27
02_Cardiac Biomarkers......Page 29
03_Inflammatory Biomarkers in
Ischemic Heart Disease......Page 55
04_Measurement of Myocardial
Contractility in the Ischemic Heart –
A Disease Immanent Uncertainty......Page 75
05_Electrical Heart Instability Evaluation in
Conditions of Diastolic Heart Failure
Suffered by Coronary Heart Disease Patients......Page 93
Part 3......Page 111
06_Prehospital Thrombolysis: It’s All About Time......Page 113
07_Thrombolysis in Myocardial Infarction......Page 135
08_Platelet Activation in Ischemic
Heart Disease: Role of Modulators
and New Therapies......Page 147
09_Myocardial Ischemia-Reperfusion/Injury......Page 175
Part 4......Page 199
10_Connexin 43 Hemichannels and
Pharmacotherapy of Myocardial Ischemia Injury......Page 201
11_Myocardial Ischemia: Alterations in
Myocardial Cellular Energy and
Diastolic Function, a Potential Role
for D-Ribose......Page 231
12_Two Novel Approaches Providing Cardiac
Protection Against Oxidative Stress......Page 241
13_Hepatic Lipid Accumulation by High Cholesterol
Diet is Inhibited by the Low Dose Fish Oil in
Male C57BL/6J Mice......Page 259
14_Cardiac Protection with Targeted Drug Delivery
to Ischemic-Reperfused Myocardium......Page 265
15_Topical Negative Pressure,
Applied onto the Myocardium,
a Potential Alternative Treatment for Patients
with Coronary Artery Disease in the Future......Page 287
16_Ischemic Heart Disease, Diabetes and
Mineralocorticoid Receptors......Page 299
Part 5......Page 311
17_Cardiology Best Practice – Effective
Health Education Meets Biomedical
Advances: Reducing the Ultimate
Knowledge Translation Gap......Page 313
18_Inpatient Costs Associated with Ischemic
Heart Disease Among Adults Aged 18-64
Years in the United States......Page 331
19_Post-Myocardial
Infarction Depression......Page 345
20_Cytochrome P450 Epoxygenase CYP2J2 G-50T
Polymorphism is an Independent Genetic
Prognostic Risk Factor and Interacts with
Smoking Cessation After Index Premature
Myocardial Infarction......Page 375
Part 6......Page 391
21_Coronary Artery Aneurysms: An Update......Page 393
22_Cardiac Function and Organ Blood Flow
at Early Stage Following Severe Burn......Page 417
23_Aging, Reactive Nitrogen Species and
Myocardial Apoptosis Induced by
Ischemia/Reperfusion Injury......Page 441